Sex: U
Vaccine: COVID19
Symptoms: Injection site swelling, Malaise, Myalgia, Pyrexia
Clinical narrative: Moderate malaise/feeling sick present with some interference with activity; Mild injection site pain and no interference with activity/ Moderate injection site tenderness (tenderness with movement); Mild injection site redness; Mild injection site swelling; Mild fever; Moderate fatigue with some interference with activity; Moderate muscle pain with some interference with activity; Joint pain with some interference with activity; This spontaneous case was reported by a non-health professional and describes the occurrence of MALAISE (Moderate malaise/feeling sick present with some interference with activity), INJECTION SITE PAIN (Mild injection site pain and no interference with activity/ Moderate injection site tenderness (tenderness with movement)), INJECTION SITE ERYTHEMA (Mild injection site redness), INJECTION SITE SWELLING (Mild injection site swelling) and PYREXIA (Mild fever) in a  patient of an unknown age and gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    In December 2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In December 2023, the patient experienced MALAISE (Moderate malaise/feeling sick present with some interference with activity), INJECTION SITE PAIN (Mild injection site pain and no interference with activity/ Moderate injection site tenderness (tenderness with movement)), INJECTION SITE ERYTHEMA (Mild injection site redness), INJECTION SITE SWELLING (Mild injection site swelling), PYREXIA (Mild fever), FATIGUE (Moderate fatigue with some interference with activity), MYALGIA (Moderate muscle pain with some interference with activity) and ARTHRALGIA (Joint pain with some interference with activity). At the time of the report, MALAISE (Moderate malaise/feeling sick present with some interference with activity), INJECTION SITE PAIN (Mild injection site pain and no interference with activity/ Moderate injection site tenderness (tenderness with movement)), INJECTION SITE ERYTHEMA (Mild injection site redness), INJECTION SITE SWELLING (Mild injection site swelling), PYREXIA (Mild fever), FATIGUE (Moderate fatigue with some interference with activity), MYALGIA (Moderate muscle pain with some interference with activity) and ARTHRALGIA (Joint pain with some interference with activity) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2023, Body temperature: 100.4 to 101.2 °F (mild fever).         Concomitant and treatment medications were not reported.  Patient experienced Mild injection site pain and no interference with activity. Moderate injection site tenderness (tenderness with movement), Mild injection site redness, Mild injection site swelling, Mild fever (100.4 to 101.2 °F), Moderate fatigue with some interference with activity, Moderate malaise/feeling sick present with some interference with activity, Moderate muscle pain with some interference with activity, Joint pain with some interference with activity which occurred on Saturday, Dec 23, 2023, and Sunday, Dec 24, 2023.   This case was linked to US-MODERNATX, INC.-MOD-2024-756099 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2024-756099:Same reporter